Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol in PTSD
NCT01221792Phase 2Unknown
- Sponsor
- Columbia Northwest Pharmaceuticals
- Start
- Oct 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carvedilol in post-traumatic stress disorder (PTSD), sponsored by Columbia Northwest Pharmaceuticals. Status: unknown.
02
Drugs
carvedilol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01221792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221792.